0001209191-14-027610.txt : 20140415 0001209191-14-027610.hdr.sgml : 20140415 20140415173808 ACCESSION NUMBER: 0001209191-14-027610 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140415 FILED AS OF DATE: 20140415 DATE AS OF CHANGE: 20140415 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TriVascular Technologies, Inc. CENTRAL INDEX KEY: 0001432732 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3910 BRICKWAY BOULEVARD CITY: SANTA ROSA STATE: CA ZIP: 95403 BUSINESS PHONE: 707-543-8800 MAIL ADDRESS: STREET 1: 3910 BRICKWAY BOULEVARD CITY: SANTA ROSA STATE: CA ZIP: 95403 FORMER COMPANY: FORMER CONFORMED NAME: TV2 HOLDING Co DATE OF NAME CHANGE: 20091116 FORMER COMPANY: FORMER CONFORMED NAME: TV2 HOLDING CO DATE OF NAME CHANGE: 20080417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOUGLASS DAVID L CENTRAL INDEX KEY: 0001271389 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14765997 MAIL ADDRESS: STREET 1: 3000 SAND HILL RD STREET 2: BUILDING 1, SUITE 135 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOCHNOWSKI JAMES J CENTRAL INDEX KEY: 0001255743 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14765998 MAIL ADDRESS: STREET 1: C/O DELPHI VENTURES STREET 2: 3000 SAND HILL ROAD STE 135 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROEDER DOUGLAS A CENTRAL INDEX KEY: 0001270735 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14765999 MAIL ADDRESS: STREET 1: 3000 DAND HILL RD, BLDG 1, STE 135 STREET 2: C/O DELPHI VENTURES CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DELPHI VENTURES VIII LP CENTRAL INDEX KEY: 0001436285 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14766003 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 1, SUITE 135 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-854-9657 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 1, SUITE 135 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Delphi Management Partners VII, L.L.C. CENTRAL INDEX KEY: 0001457493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14766004 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD, 1-135 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-854-9650 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD, 1-135 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Delphi Management Partners VIII, L.L.C. CENTRAL INDEX KEY: 0001457494 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14766005 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD, 1-135 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-854-9650 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD, 1-135 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DELPHI VENTURES VII L P CENTRAL INDEX KEY: 0001336922 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14766002 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL RD STREET 2: BUILDING 1 SUITE 135 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-854-9650 MAIL ADDRESS: STREET 1: 3000 SAND HILL RD STREET 2: BUILDING 1 SUITE 135 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAKIANATHAN DEEPIKA CENTRAL INDEX KEY: 0001270734 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14765996 MAIL ADDRESS: STREET 1: 3000 SAND HILL RD, BLDG 1, STE 135 STREET 2: C/O DELPHI VENTURES CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DELPHI BIOINVESTMENTS VII LP CENTRAL INDEX KEY: 0001346198 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14766000 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 1 STE 135 CITY: MENLO PARK STATE: CA ZIP: 94025 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 1 STE 135 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Delphi BioInvestments VIII LP CENTRAL INDEX KEY: 0001451526 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36419 FILM NUMBER: 14766001 BUSINESS ADDRESS: STREET 1: 300 Sand Hill Rd STREET 2: Building 1 Suite 135 CITY: Menlo Park STATE: CA ZIP: 94025 BUSINESS PHONE: 650 854 9650 MAIL ADDRESS: STREET 1: 300 Sand Hill rd STREET 2: Building 1 Suite 135 CITY: Menlo pARK STATE: ca ZIP: 94025 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2014-04-15 0 0001432732 TriVascular Technologies, Inc. TRIV 0001457494 Delphi Management Partners VIII, L.L.C. 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 0001457493 Delphi Management Partners VII, L.L.C. 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 0001436285 DELPHI VENTURES VIII LP 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 0001336922 DELPHI VENTURES VII L P 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 0001451526 Delphi BioInvestments VIII LP 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 0001346198 DELPHI BIOINVESTMENTS VII LP 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 0001270735 ROEDER DOUGLAS A C/O DELPHI VENTURES 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 1 0 1 0 0001255743 BOCHNOWSKI JAMES J C/O DELPHI VENTURES 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 0001271389 DOUGLASS DAVID L C/O DELPHI VENTURES 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 0001270734 PAKIANATHAN DEEPIKA C/O DELPHI VENTURES 3000 SAND HILL ROAD, BLDG.1, SUITE 135 MENLO PARK CA 94025 0 0 1 0 Series A Preferred Stock Common Stock 574933 I See Footnote Series B Preferred Stock Common Stock 384594 I See Footnotes Series C Preferred Stock Common Stock 424918 I See Footnote Series D Preferred Stock Common Stock 970167 I See Footnote Series E Preferred Stock Common Stock 347965 I See Footnote Series D Preferred Warrants 15.8061 2019-02-02 Common Stock 45094 I See Footnote Each share of Series A Preferred Stock and each share of Series B Preferred Stock is convertible into 0.03845959625192770 of a share of Common Stock without payment of further consideration and will automatically convert into 0.03845959625192770 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The number of securities reported in Table II is shown on a post-conversion basis. The shares have no expiration date. These securities are directly held as follows: 569,241 shares by Delphi Ventures VII, L.P. ("Ventures VII") and 5,692 shares by Delphi BioInvestments VII, L.P. ("BioInvestments VII" and together with Ventures VII, the "Delphi VII Funds"). Delphi Management Partners VII, L.L.C. ("DMP VII") is the general partner of each of Ventures VII and BioInvestments VII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VII Funds. Douglas A. Roeder, James L. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of DMP VII and may be deemed to share voting and dispositive power over the securities held by the Delphi VII Funds. Such persons and entities disclaim beneficial ownership of the securities held by the Delphi VII Funds, except to the extent of any pecuniary interest therein. These securities are directly held as follows: 114,236 shares by Ventures VII, 1,142 shares by BioInvestments VII, 266,613 shares by Delphi Ventures VIII, L.P. ("Ventures VIII") and 2,603 shares by Delphi BioInvestments VIII, L.P. ("BioInvestments VIII" and together with Ventures VIII, the "Delphi VIII Funds" and collectively with the Delphi VII Funds, the "Delphi Funds"). DMP VII is the general partner of each of Ventures VII and BioInvestments VII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VII Funds. Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of each of Ventures VIII and BioInvestments VIII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VIII Funds. Douglas A. Roeder, James L. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of each of DMP VII and DMP VIII and may be deemed to share voting and dispositive power over the securities held by the Delphi Funds. Such persons and entities disclaim beneficial ownership of the securities held by the Delphi Funds, except to the extent of any pecuniary interest therein. Each share of Series C Preferred Stock is convertible into 0.03899558573514530 of a share of Common Stock without payment of further consideration and will automatically convert into 0.03899558573514530 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The number of securities reported in Table II is shown on a post-conversion basis. The shares have no expiration date. These securities are directly held as follows: 105,298 shares by Ventures VII, 1,052 shares by BioInvestments VII, 315,489 shares by Ventures VIII and 3,079 shares by BioInvestments VIII. DMP VII is the general partner of each of Ventures VII and BioInvestments VII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VII Funds. DMP VIII is the general partner of each of Ventures VIII and BioInvestments VIII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VIII Funds. Douglas A. Roeder, James L. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of each of DMP VII and DMP VIII and may be deemed to share voting and dispositive power over the securities held by the Delphi Funds. Such persons and entities disclaim beneficial ownership of the securities held by the Delphi Funds, except to the extent of any pecuniary interest therein. Each share of Series D Preferred Stock and each share of Series E Preferred Stock is convertible into 0.0246487552378605 of a share of Common Stock without payment of further consideration and will automatically convert into 0.02464875523786050 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The number of securities reported in Table II is shown on a post-conversion basis. The shares have no expiration date. These securities are directly held as follows: 270,867 shares by Ventures VII, 2,707 shares by BioInvestments VII, 689,858 shares by Ventures VIII and 6,735 shares by BioInvestments VIII. DMP VII is the general partner of each of Ventures VII and BioInvestments VII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VII Funds. DMP VIII is the general partner of each of Ventures VIII and BioInvestments VIII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VIII Funds. Douglas A. Roeder, James L. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of each of DMP VII and DMP VIII and may be deemed to share voting and dispositive power over the securities held by the Delphi Funds. Such persons and entities disclaim beneficial ownership of the securities held by the Delphi Funds, except to the extent of any pecuniary interest therein. These securities are directly held as follows: 157,386 shares by Ventures VII, 1,573 shares by BioInvestments VII, 187,179 shares by Ventures VIII and 1,827 shares by BioInvestments VIII. DMP VII is the general partner of each of Ventures VII and BioInvestments VII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VII Funds. DMP VIII is the general partner of each of Ventures VIII and BioInvestments VIII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VIII Funds. Douglas A. Roeder, James L. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of each of DMP VII and DMP VIII and may be deemed to share voting and dispositive power over the securities held by the Delphi Funds. Such persons and entities disclaim beneficial ownership of the securities held by the Delphi Funds, except to the extent of any pecuniary interest therein. Immediately. These securities are directly held as follows: 25,754 shares by Ventures VII, 257 shares by BioInvestments VII, 18,899 shares by Ventures VIII and 184 shares by BioInvestments VIII. DMP VII is the general partner of each of Ventures VII and BioInvestments VII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VII Funds. DMP VIII is the general partner of each of Ventures VIII and BioInvestments VIII and may be deemed to have sole voting and dispositive power over the securities held by the Delphi VIII Funds. Douglas A. Roeder, James L. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of each of DMP VII and DMP VIII and may be deemed to share voting and dispositive power over the securities held by the Delphi Funds. Such persons and entities disclaim beneficial ownership of the securities held by the Delphi Funds, except to the extent of any pecuniary interest therein. Exhibit 24 -Power of Attorney By: /s/ Matthew T. Potter, Attorney-In-Fact for Delphi Management Partners VIII, L.L.C. 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for Delphi Management Partners VII, L.L.C. 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for Delphi Ventures VIII, L.P. 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for Delphi Ventures VII, L.P. 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for Delphi BioInvestments VIII, L.P. 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for Delphi BioInvestments VII, L.P. 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for Douglas Roeder 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for James T. Bochnowski 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for David L. Douglass 2014-04-15 By: /s/ Matthew T. Potter, Attorney-In-Fact for Deepika R. Pakianathan 2014-04-15 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                POWER OF ATTORNEY

        Each of the undersigned entities and individuals (each, a "Reporting
Person") hereby constitutes and appoints MATTHEW T. POTTER his, her or its true
and lawful attorney-in-fact (the "Attorney-in-Fact") to:

        (1)     Prepare, execute in the Reporting Persons' names and on the
Reporting Persons' behalves, and submit to the U.S. Securities and Exchange
Commission (the "SEC") a Form ID, including amendments thereto, and any other
documents necessary or appropriate to obtain codes and passwords enabling such
Reporting Person to make electronic filings with the SEC of Reports required by
Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation
of the SEC;

        (2)     Prepare, execute and file on behalf of such Reporting Person
individually, or jointly together with the other Reporting Persons, any and all
reports, notices, communications and other documents (including, but not limited
to, reports on Schedule 13D, Schedule 13G, Form 13F, Form 3, Form 4 and Form 5)
that such Reporting Person may be required to file with the SEC pursuant to the
Securities Act of 1933, as amended (together with the implementing regulations
thereto, the "Act") and the Securities Exchange Act of 1934, as amended
(together with the implementing regulations thereto, the "Exchange Act")
(collectively, the "Reports") with respect to each Reporting Person's (a) status
as an officer or director of, or (b) ownership of, or transactions in,
securities of, any entity whose securities are beneficially owned (directly or
indirectly) by such Reporting Person (collectively, the "Companies");

        (3)     Do and perform any and all acts for and on behalf of such
Reporting Person that may be necessary or desirable to complete and execute any
such Reports, complete and execute any amendment or amendments thereto, and
timely file such forms and schedules with the SEC and any stock exchange or
similar authority; and

        (4)     Take any other action of any type whatsoever in connection with
the foregoing which, in the opinion of the Attorney-in-Fact, may be of benefit
to, in the best interest of, or legally required by, such Reporting Person, it
being understood that the documents executed by the Attorney-in-Fact on behalf
of such Reporting Person, pursuant to this Power of Attorney, shall be in such
form and shall contain such terms and conditions as the Attorney-in-Fact may
approve in his discretion.

        Each Reporting Person hereby grants to the Attorney-in-Fact full power
and authority to do and perform all and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as such
Reporting Person might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that the
Attorney-in-Fact, or his substitute or substitutes, shall lawfully do or cause
to be done by virtue of this Power of Attorney and the rights and powers herein
granted. Each Reporting Person acknowledges that the Attorney-in-Fact, in
serving in such capacity at the request of the Reporting Persons, is not hereby
assuming, nor is the Company hereby assuming, any of such Reporting Person's
responsibilities to comply with Section 16 or Section 13 of the Exchange Act.

        This Power of Attorney shall remain in full force and effect with
respect to each Reporting Person until such Reporting Person is no longer
required to file Forms 3, 4 and 5 or Schedules 13G/D with respect to such
Reporting Person's holdings of and transactions in securities issued by the
Company, unless earlier revoked by such Reporting Person in a signed writing
delivered to the Attorney-in-Fact. Each Reporting Person acknowledges that the
Attorney-in-Fact, in serving in such capacity at the request of the Reporting
Persons, is not hereby assuming any of the Reporting Persons' responsibilities
to comply with state or federal securities laws.

                      [SIGNATURES ON THE FOLLOWING PAGES.]

        IN WITNESS WHEREOF, each of the undersigned has caused this Power of
Attorney to be executed as of this 26th day of February, 2009.

DELPHI MANAGEMENT PARTNERS VIII,L.L.C.

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI VENTURES VIII, L.P.

By: Delphi Management Partners VIII, L.L.C.
    Its General Partner

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI BIOINVESTMENTS VIII, L.P.

By: Delphi Management Partners VIII, L.L.C.
    Its General Partner

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI MANAGEMENT PARTNERS VII, L.L.C.

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI VENTURES VII, L.P.

By: Delphi Management Partners VII, L.L.C.
    Its General Partner

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI BIOINVESTMENTS VII, L.P.

By: Delphi Management Partners VII, L.L.C.
    Its General Partner

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI MANAGEMENT PARTNERS VI, L.L.C.

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI VENTURES VI, L.P.

By: Delphi Management Partners VI, L.L.C.
    Its General Partner

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI BIOINVESTMENTS VI, L.P.

By: Delphi Management Partners VII, L.L.C.
    Its General Partner

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI MANAGEMENT PARTNERS V, L.L.C.

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI VENTURES V, L.P.

By: Delphi Management Partners V, L.L.C.
    Its General Partner

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

DELPHI BIOINVESTMENTS V, L.P.

By: Delphi Management Partners V, L.L.C.
    Its General Partner

By: /s/ JAMES J. BOCHNOWSKI
    ------------------------------------
    Name:  JAMES J. BOCHNOWSKI
    Title: Managing Member

    JAMES J. BOCHNOWSKI
    /s/ JAMES J. BOCHNOWSKI
    ------------------------------------

    DAVID L. DOUGLASS
    /s/ DAVID L. DOUGLASS
    ------------------------------------

    DONALD J. LOTHROP

    ------------------------------------

    JOHN F. MARONEY
    /s/ JOHN F. MARONEY
    ------------------------------------

    KEVIN L. ROBERG

    ------------------------------------

    DOUGLAS A. ROEDER
    /s/ DOUGLAS A. ROEDER
    ------------------------------------

    DEEPIKA R. PAKIANATHAN, PH.D.
    /s/ DEEPIKA R. PAKIANATHAN, PH.D.
    ------------------------------------

    JAMES J. BOCHNOWSKI
    /s/JAMES J. BOCHNOWSKI
    ------------------------------------

    DAVID L. DOUGLASS
    /s/ DAVID L. DOUGLASS
    ------------------------------------

    DONALD J. LOTHROP
    /s/ DONALD J. LOTHROP
    ------------------------------------

    JOHN F. MARONEY
    /s/ JOHN F. MARONEY
    ------------------------------------

    KEVIN L. ROBERG

    ------------------------------------

    DOUGLAS A. ROEDER
    /s/ DOUGLAS A. ROEDER
    ------------------------------------

    DEEPIKA R. PAKIANATHAN, PH.D.
    /s/ DEEPIKA R. PAKIANATHAN, PH.D.
    ------------------------------------

    JAMES J. BOCHNOWSKI
    /s/ JAMES J. BOCHNOWSKI
    ------------------------------------

    DAVID L. DOUGLASS
    /s/ DAVID L. DOUGLASS
    ------------------------------------

    DONALD J. LOTHROP

    ------------------------------------

    JOHN F. MARONEY
    /s/ JOHN F. MARONEY
    ------------------------------------

    KEVIN L. ROBERG
    /s/ KEVIN L. ROBERG
    ------------------------------------

    DOUGLAS A. ROEDER
    /s/ DOUGLAS A. ROEDER
    ------------------------------------

    DEEPIKA R. PAKIANATHAN, PH.D.
    /s/ DEEPIKA R. PAKIANATHAN, PH.D.
    ------------------------------------